Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Transgenic mice lacking FGF15/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease

Journal of Biological Chemistry(2023)10.1016/j.jbc.2023.104946Source: DataRank Database

Transgenic mice lacking FGF15/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease is a research paper published in Journal of Biological Chemistry (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

refseq doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.01)OA: goldTopics (53)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Ming Qi ORCID,Xingchen Dong ORCID,Sunmi Seok,Hao Sun ORCID,Byron Kemper

Live enrichment

PubMed:37348559 PMC:PMC10359637 OpenAlex:https://openalex.org/W4381325896

American Cancer Society

Grant: MSN228402

American Heart Association

Grant: 16SDG27570006

National Institutes of Health

Grant: R01DK062777

National Institutes of Health

Grant: R01DK095842

College of Engineering, University of Wisconsin-Madison

University of Illinois at Urbana-Champaign

FWCI

1.01

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.jbc.org/article/S0021925823019749/pdf

publisherhttp://www.jbc.org/article/S0021925823019749/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0021925823019749?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0021925823019749?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jbc.2023.104946

Fields of Study

Fibroblast Growth Factor ResearchLiver Disease Diagnosis and TreatmentEpigenetics and DNA MethylationAnimalsMaleMiceAnti-Bacterial AgentsBile Acids and SaltsGastrointestinal MicrobiomeLipidsMice, Inbred C57BLMice, TransgenicNon-alcoholic Fatty Liver DiseaseObesityPhosphorylationReceptors, Cytoplasmic and NuclearFibroblast Growth Factors

MeSH Terms

Gastrointestinal MicrobiomeAnimalsAnti-Bacterial AgentsBile Acids and SaltsFibroblast Growth FactorsLipidsMaleMice, Inbred C57BLMice, TransgenicObesityPhosphorylationReceptors, Cytoplasmic and NuclearMiceNon-alcoholic Fatty Liver Disease

Keywords

Nonalcoholic fatty liver diseaseGenetically modified mouseBacteriaTransgeneBiochemistryBile acidBiologyPhosphorylationMicrobiologyChemistryFatty liverDiseaseInternal medicineMedicineGeneGeneticslipid metabolismGut MicrobiotaFxrLipophagyNafldBile Acid Composition

Sustainable Development Goals

SDG 0: Affordable and clean energy

Transgenic mice lacking FGF15/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease

FAIR Checklist

Authors (8)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)